Inhibition of Osteoblastic Function in the Osteoporosis of Copper Deficiency in Dogs

Key Words

Copper deficiency - Dog - Osteoporosis - Osteoblast function

• REFERENCES

• 1 Suttle N F, Angus K W, Nisbet D I, Field A C. Osteoporosis in copper-depleted lambs. J Comp Path 1972; 83: 93-7.
• 2 Suttle N F, Angus K W. Effects of experimental copper deficiency on the skeleton of the calf. J Comp Path 1978; 88: 137-48.
• 3 Carlton W W, Henderson W. Skeletal lesions in experimental copper deficiency in chickens. Avian Dis 1964; 8: 48-55.
• 4 Follis R H, Bush J A, Cartwright G E, Wintrobe M M. Studies on copper metabolism XVIII. Skeletal changes associated with copper deficiency in swine. Bull Johns Hopkins Hosp 1955; 97: 405-13.
• 5 Baxter J H, Van Wyk J J. A bone disorder associated with copper deficiency. I Gross morphological, roentgenological and chemical observations. Bull Johns Hopkins Hosp 1953; 93: 1-24.
• 6 Alfaro B, Heaton F W. Relationships between copper, zinc and iron in the plasma, soft tissues and skeleton of the rat during copper deficiency. Br J Nutr 1973; 29: 73-85.
• 7 Gallagher C H. The pathology and biochemistry of copper deficiency. Aust vet J. 33: 311-7.
• 8 Cunningham I J. Copper and molybdenum in relation to diseases of cattle and sheep in New Zealand. In: McElroy W D, Glass B. (eds). Copper Metabolism. A Symposium on Animal, Plant and Soil Relationships. Baltimore: Johns Hopkins Press; 1950: 246-73.
• 9 Smith B P, Fisher G L, Poulos P W, Irwin M R. Abnormal bone development and lameness associated with secondary copper deficiency in young cattle. J Am Vet Med Assoc 1975; 166: 682-8.
• 10 Spence J A, Suttle N F, Wenham G, El-Gallad T, Bremner I. A sequential study of the skeletal abnormalities which develop in rats given a small dietary supplement of ammonium tetrathiomolybdate. J Comp Path 1980; 90: 139-53.
• 11 Lalich J J, Groupner K, Jolin J. The influence of copper and molybdate salts on the production of bony deformities in rats. Lab Invest 1965; 14: 1482-93.
• 12 Paynter D I. An improved assay of ceruloplasmin activity in domestic species. Proc Nutr Soc Aust 1980; 5: 183.
• 13 Paynter D I, Allen J D. Superoxide dismutase and copper deficiency in ruminants. In: Howell J, Mc C, Gawthorne J M, White C L. (eds). Trace Element Metabolism in Man and Animals IV. Canberra, Aust: Aust Academy of Science; 1981: 374-7.
• 14 Meunier P J. Histomorphometry of the Skeleton. In: Peck W A. (ed). Bone and Mineral Research Annual Vol 1, Chap 5. Amsterdam: Excerpta Medica; 1983: 192-231.
• 15 Frost H M. Histomorphometry of trabecular bone I. Theoretical correction of appositional rate measurements. In: Meunier P J. (ed). Bone Histomorphometry. 2nd International Workshop. Société de la Nouvelle Imprimerie Fournie; Toulouse, France: 1976: 361-70.
• 16 Fiske C H, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925; 66: 375-400.
• 17 Price R I, Barnes M P, Gutteridge D H, Baron-Hay M, Prince R L, Retallack R W. Ultra-distal and cortical forearm bone density in the assessment of postmenopausal bone loss and non-axial fracture risk. J Bone Min Res. 1988 (In Press).
• 18 Price P A, Nishimoto S K. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci USA 1980; 77: 2234-8.
• 19 Gindler E M, King J D. Rapid colorimetric determination of calcium in biological fluids with methylthymol blue. Am J Clin Pathol 1972; 58: 376-82.
• 20 Gindler E M, Ishizaki R T. Rapid semimicro colorimetric determination of phosphorus in serum and nonionic surfactants. Clin Chem 1969; 15: 807.
• 21 Bowers G N, McComb R B. A continuous spectrophotometric method for measuring the activity of serum alkaline phosphatase. Clin Chem 1966; 12: 21-9.
• 22 Urist M R, Lietze A, Mizutani H, Tagaki K, Triffitt J T, Amstutz J, Delange R, Termine J, Finerman G A. A bovine low molecular weight bone morphogenetic protein (BMP) fraction. Clin Orthop 1982; 162: 219-32.
• 23 Urist M R, Delange R J, Finerman G A M. Bone cell differentiation and growth factors: Induced activity of chondro-osteogenetic DNA. Science 1983; 220: 680-6.
• 24 Mundy G R, Poser J W. Chemotactic activity of the y-carboxyglutamic acid-containing protein in bone. Calcif Tissue Int 1983; 35: 164-8.
• 25 Mundy G R, De Martino S, Rowe D W. Collagen and collagen-derived fragments are chemotactic for tumor cells. J Clin Invest 1981; 68: 1102-5.
• 26 Ausprunk D, Folkman J. Migration and proliferation of endothelial cells in performed and newly formed blood vessels during tumour angiogenesis. Microvasc Res 1977; 14: 53-6.
• 27 McAuslan B R, Hannan G N, Reilly W G, Stewart F H C. Variant endothelial cells: Fibronectin as a transducer of signals for migration and neovascularisation. J Cell Physiol 1980; 104: 177-86.
• 28 Gullino P M. Considerations on the mechanism of the angiogenic response. Anticancer Res 1986; 6: 153-8.
• 29 Baxter J H, Van Wyk J J, Follis R H. A bone disorder associated with copper deficiency. II Histological and chemical studies on the bones. Bull Johns Hopkins Hosp 1953; 93: 25-39.
• 30 Revell P A. Histomorphometry of bone. J Clin Pathol 1983; 36: 1323-31.
• 31 Malluche H H, Faugere M C, Friedler R M. An osteoblastic defect is responsible for maintenance of Bone loss after ovariectomy in dogs. In: Proc 4th International Symposium on Bone Structure. Function and Disease. Sydney, Australia: 1987. Abstr 33.
• 32 Meunier P J, Edouard C, Courpron P, Toussaint F. Morphometric analysis of osteoid in iliac trabecular bone. In: Norman A W. (ed). Vitamin D and Problems Related to Uremic Bone Disease. Walter de Gruyter; Berlin: 1975: 149-55.
• 33 Hauschka P V. Osteocalcin and its functional domains. In: Butler W. (ed). The Chemistry and Biology of Mineralised Tissues. Alabama: Ebsco Media Inc Birmingham; 1984: 149-55.
• 34 Gundberg C M, Lian J B, Gallop P M, Steinberg J J. Urinary γ-carboxyglutamic acid and serum osteocalcin as bone markers: Studies in osteoporosis and Paget’s disease. J Clin Endocrinol Metab 1983; 57: 1221-5.